Education
#68: glyburide (Diabeta, Glynase, Micronase) | Lowers Blood Glucose in Patients with Diabetes
2022-01-31
Glyburide also goes by the brand names of Diabeta, Glynase, and Micronase. It is most commonly used in the treatment of patients with type 2 diabetes. The dosing range varies and is based on the patients blood glucose and the level of control needed. The treatment range is between 1.25-20 mg PO divided 1-2 times daily. Glyburide is given with meals. The mechanism of action lowers blood glucose through the stimulation of pancreatic beta cells. It is very important to note that the conventional and micronized tablets are not interchangeable. The comparison is approximately 1.25 mg to 0.75 mg. Common side effects are weight gain, epigastric discomfort, and blurred vision. The more serious side effects are a disulfiram-like reaction, hypoglycemia, and agranulocytosis.
Amazon Affiliate link: https://amzn.to/31OkKVe for NAPLEX Math Review: The Foundation of a Logical NAPLEX Prep Strategy.
FREE Drug Card Sheet is available for this episode at DrugCardsDaily.com along with ALL past FREE drug card sheets! Please SUBSCRIBE, FOLLOW, and RATE on Spotify, Apple Podcasts, or wherever your favorite place to listen to podcasts are. I’d really appreciate hearing from you! Leave a voice message at anchor.fm/drugcardsdaily or find me on most all socials @drugcardsdaily or send an email to contact.drugcardsdaily@gmail.com to leave feedback, request a drug, or say hello!
DISCLAIMER: This content may contain sponsored content or the use of affiliate links. Partnerships, sponsorships, and the use of affiliate links provide monetary commissions for Drug Cards Daily at no cost to you! This is done in order to keep providing as much free content to everyone that comes to Drug Cards Daily. Thanks for your support! Drug Cards Daily provides drug information for educational and entertainment use. The information provided is not intended to be a sole source of drug information that is to be acted upon for patient care. If there are drug-related patient care concerns please contact your primary care Physician or local Pharmacist.
More Episodes
Get this podcast on your
phone, FREE
